Kite Pharma
biomedical engineering company that develops cancer immunotherapy products
Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.
Kite Pharma’s social media accounts
Social
Web
1 external identifier
Something wrong with this entry? Report it · How corrections work
Last updated · Handles last checked · How we check